↓ Skip to main content

Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases

Overview of attention for article published in BMC Immunology, August 2010
Altmetric Badge

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
38 Mendeley